Latest filing published 24 Aug 2026 for Beryl Drugs.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +1.3%Entry ₹25.48 · Close at T+30 ₹25.80
- +7.0%Entry ₹22.00 · Close at T+30 ₹23.53
- +3.6%Entry ₹22.20 · Close at T+30 ₹22.99
- +3.7%Entry ₹21.90 · Close at T+90 ₹22.70
- +2.1%Entry ₹23.50 · Close at T+90 ₹23.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sudhir Sethi: trading record in brief
Sudhir Sethi discloses dealings in Beryl Drugs to SEBI (PIT + SAST). Over a trading history stretching from 7 June 2026 to 24 August 2026, the count stands at 12 filings.
The open-market record is one-sided, with 12 purchases worth €3,042 and not one sale. The totals do not cover 7 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €623. As a share of market capitalisation, the median purchase stands at 0.067%, based on 4 purchases. Across 10 purchases, this insider has always bought alone, with no colleague buying within 30 days. Ninety days after publication, 3 purchases show a median change of +1.9%, with the price up in 100% of them. This is a record of the past, not a forecast.
The newest entry dates from 24 August 2026: an open-market purchase, in Beryl Drugs. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sudhir Sethi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares-MarketSEBI:76174dd04aab1be261ec2cc56ab33189988c6302Canonical exit: 22 Nov 2026 (T+90)
- 4,809 shares-MarketSEBI:fe369378dd180e18d582aee36ecd381ebe55dcccCanonical exit: 22 Nov 2026 (T+90)
- 4,809 shares@ ₹23.000.095% mcap32.7% of flowEquityMarket PurchaseSEBI:6b2d3b91da8600f142e36574857ec2540e736764Canonical exit: 17 Nov 2026 (T+90)
- 3,000 shares@ ₹23.000.059% mcap20.5% of flowEquityMarket PurchaseSEBI:b12862567d2a23cf34966e18c726b7e70779015dCanonical exit: 16 Nov 2026 (T+90)
- 6,950 shares-MarketSEBI:ce1bfd3c3db694d98810fe5782b323d924a4272aCanonical exit: 14 Oct 2026 (T+90)
- 1,992 shares-MarketSEBI:40b7fbdb8d06de15ddf58d7b74849c3e97a314dfCanonical exit: 15 Sept 2026 (T+90)
- 3,482 shares-MarketSEBI:f08604d79c000fed86c0ad77be27ba8d8438873eCanonical exit: 15 Sept 2026 (T+90)
- 4,682 shares-MarketSEBI:530e5b8895b90e69ad5e65876b0fdf57080418cfCanonical exit: 15 Sept 2026 (T+90)
- 30 shares-MarketSEBI:eb42d37f8d98b4c7a7399a34cd244e3b840e8218Canonical exit: 15 Sept 2026 (T+90)
- 30 shares@ ₹23.500.0006% mcap0.2% of flowEquity SharesMarket PurchaseSEBI:595b5ff051ac5a14d4d7336b9c8cc0750a5ba482Canonical exit: 10 Sept 2026 (T+90)
- 4,682 shares@ ₹24.000.088% mcap33.6% of flowEquity SharesMarket PurchaseSEBI:98926893d7a2c99c398ecb3a859d9ab11f7762d3Canonical exit: 7 Sept 2026 (T+90)
- 1,992 shares@ ₹21.9013.0% of flowEquity SharesMarket PurchaseSEBI:871849245ba4ff15416a55af3e35553ca46d23faCanonical exit: 5 Sept 2026 (T+90)
12 of 12 declarations